Literature DB >> 18508789

The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia.

Thorsten Zenz, Sonja Häbe, Axel Benner, Dirk Kienle, Hartmut Döhner, Stephan Stilgenbauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18508789     DOI： 10.3324/haematol.12738

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

1.  Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma.

Authors:  David Wrench; Rachel Waters; Emanuela Carlotti; Sameena Iqbal; Janet Matthews; Marie Calaminici; John Gribben; T Andrew Lister; Jude Fitzgibbon
Journal:  Haematologica       Date:  2008-11-23       Impact factor: 9.941

Review 2.  The role of TP53 network in the pathogenesis of chronic lymphocytic leukemia.

Authors:  Cheng Wang; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

3.  MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis.

Authors:  Axel Benner; Larry Mansouri; Davide Rossi; Aneela Majid; Kerstin Willander; Anton Parker; Gareth Bond; Sarka Pavlova; Holger Nückel; Olaf Merkel; Paolo Ghia; Emili Montserrat; Mohd Arifin Kaderi; Richard Rosenquist; Gianluca Gaidano; Martin J S Dyer; Peter Söderkvist; Mats Linderholm; David Oscier; Zuzana Tvaruzkova; Sarka Pospisilova; Ulrich Dührsen; Richard Greil; Hartmut Döhner; Stephan Stilgenbauer; Thorsten Zenz
Journal:  Haematologica       Date:  2014-08       Impact factor: 9.941

4.  MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.

Authors:  Yan Wan; Wei Wu; Zhihua Yin; Peng Guan; Baosen Zhou
Journal:  BMC Cancer       Date:  2011-05-29       Impact factor: 4.430

Review 5.  Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.

Authors:  Sean M Post; Vinod Pant; Hussein Abbas; Alfonso Quintás-Cardama
Journal:  Oncotarget       Date:  2010-07

6.  Genetic variation in cell death genes and risk of non-Hodgkin lymphoma.

Authors:  Johanna M Schuetz; Denise Daley; Jinko Graham; Brian R Berry; Richard P Gallagher; Joseph M Connors; Randy D Gascoyne; John J Spinelli; Angela R Brooks-Wilson
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

7.  MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.

Authors:  Ana E Rodríguez-Vicente; Dalia Quwaider; Rocío Benito; Irena Misiewicz-Krzeminska; María Hernández-Sánchez; Alfonso García de Coca; Rosa Fisac; José-María Alonso; Carolina Zato; Juan Francisco de Paz; Juan Luis García; Ma Eugenia Sarasquete; José Ángel Hernández; Juan M Corchado; Marcos González; Norma C Gutiérrez; Jesús-María Hernández-Rivas
Journal:  BMC Cancer       Date:  2015-04-08       Impact factor: 4.430

8.  Correlations between MDM2 gene SNP309 polymorphism and susceptibility to leukemia.

Authors:  Wen-Bin Ou
Journal:  Med Sci Monit       Date:  2015-01-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.